CBIOCrescent Biopharma, Inc.

$12.87+1.1% 1Y

Is the price fair?

What CBIO's price assumes

Price / book
90.0

Price / book · as of 2024-Q2

Details›
Price / bookas of 2024-Q2
90.0
Market capitalisation37.1 million shares, counted Jul 27, 2026
$478M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.